Annual Long Term Debt
$1.25 B
-$9.71 M-0.77%
December 31, 2024
Summary
- As of February 20, 2025, ALNY annual long term debt is $1.25 billion, with the most recent change of -$9.71 million (-0.77%) on December 31, 2024.
- During the last 3 years, ALNY annual long term debt has risen by +$297.12 million (+31.05%).
- ALNY annual long term debt is now -1.89% below its all-time high of $1.28 billion, reached on December 31, 2022.
Performance
ALNY Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$1.25 B
-$5.52 M-0.44%
December 31, 2024
Summary
- As of February 20, 2025, ALNY quarterly long term debt is $1.25 billion, with the most recent change of -$5.52 million (-0.44%) on December 31, 2024.
- Over the past year, ALNY quarterly long term debt has dropped by -$9.71 million (-0.77%).
- ALNY quarterly long term debt is now -2.19% below its all-time high of $1.28 billion, reached on September 30, 2022.
Performance
ALNY Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
ALNY Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -0.8% | -0.8% |
3 y3 years | +31.1% | -0.8% |
5 y5 years | +354.2% | -0.8% |
ALNY Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -1.9% | +31.1% | -2.2% | +32.0% |
5 y | 5-year | -1.9% | +354.2% | -2.2% | +354.8% |
alltime | all time | -1.9% | >+9999.0% | -2.2% | >+9999.0% |
Alnylam Pharmaceuticals Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $1.25 B(-0.8%) | $1.25 B(-0.4%) |
Sep 2024 | - | $1.26 B(-0.2%) |
Jun 2024 | - | $1.26 B(+0.2%) |
Mar 2024 | - | $1.26 B(-0.3%) |
Dec 2023 | $1.26 B(-1.1%) | $1.26 B(-0.3%) |
Sep 2023 | - | $1.27 B(-0.4%) |
Jun 2023 | - | $1.27 B(-0.4%) |
Mar 2023 | - | $1.28 B(-0.1%) |
Dec 2022 | $1.28 B(+33.6%) | $1.28 B(-0.3%) |
Sep 2022 | - | $1.28 B(+35.0%) |
Jun 2022 | - | $949.74 M(-0.5%) |
Mar 2022 | - | $954.10 M(-0.3%) |
Dec 2021 | $957.04 M(+97.6%) | $957.04 M(+33.0%) |
Sep 2021 | - | $719.83 M(-0.3%) |
Jun 2021 | - | $721.71 M(+50.5%) |
Mar 2021 | - | $479.61 M(-1.0%) |
Dec 2020 | $484.32 M(+75.4%) | $484.32 M(+62.9%) |
Sep 2020 | - | $297.26 M(+5.6%) |
Jun 2020 | - | $281.62 M(+2.1%) |
Mar 2020 | - | $275.78 M(-0.1%) |
Dec 2019 | $276.13 M(+820.4%) | $276.13 M(-0.1%) |
Sep 2019 | - | $276.46 M(-10.0%) |
Jun 2019 | - | $307.21 M(-1.6%) |
Mar 2019 | - | $312.30 M(+941.0%) |
Dec 2018 | $30.00 M | $30.00 M(0.0%) |
Sep 2018 | - | $30.00 M(0.0%) |
Jun 2018 | - | $30.00 M(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $30.00 M(0.0%) |
Dec 2017 | $30.00 M(-80.0%) | $30.00 M(-80.0%) |
Sep 2017 | - | $150.00 M(0.0%) |
Jun 2017 | - | $150.00 M(0.0%) |
Mar 2017 | - | $150.00 M(0.0%) |
Dec 2016 | $150.00 M(+4962.4%) | $150.00 M(0.0%) |
Sep 2016 | - | $150.00 M(0.0%) |
Jun 2016 | - | $150.00 M(>+9900.0%) |
Sep 2008 | - | $719.00 K(-23.3%) |
Jun 2008 | - | $938.00 K(-52.0%) |
Mar 2008 | - | $1.96 M(-34.0%) |
Dec 2007 | $2.96 M(-49.9%) | $2.96 M(-24.9%) |
Sep 2007 | - | $3.95 M(-19.6%) |
Jun 2007 | - | $4.91 M(-3.1%) |
Mar 2007 | - | $5.07 M(-14.4%) |
Dec 2006 | $5.92 M(+7.2%) | $5.92 M(-8.0%) |
Sep 2006 | - | $6.44 M(+1.6%) |
Jun 2006 | - | $6.33 M(+19.1%) |
Mar 2006 | - | $5.32 M(-3.6%) |
Dec 2005 | $5.52 M(-13.9%) | $5.52 M(-4.5%) |
Sep 2005 | - | $5.78 M(-6.5%) |
Jun 2005 | - | $6.19 M(-4.5%) |
Mar 2005 | - | $6.48 M(+1.0%) |
Dec 2004 | $6.41 M(+392.8%) | $6.41 M(-2.7%) |
Sep 2004 | - | $6.59 M(+15.5%) |
Jun 2004 | - | $5.71 M(+203.6%) |
Mar 2004 | - | $1.88 M(+44.4%) |
Dec 2003 | $1.30 M | $1.30 M |
FAQ
- What is Alnylam Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual long term debt year-on-year change?
- What is Alnylam Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly long term debt year-on-year change?
What is Alnylam Pharmaceuticals annual long term debt?
The current annual long term debt of ALNY is $1.25 B
What is the all time high annual long term debt for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual long term debt is $1.28 B
What is Alnylam Pharmaceuticals annual long term debt year-on-year change?
Over the past year, ALNY annual long term debt has changed by -$9.71 M (-0.77%)
What is Alnylam Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of ALNY is $1.25 B
What is the all time high quarterly long term debt for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly long term debt is $1.28 B
What is Alnylam Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, ALNY quarterly long term debt has changed by -$9.71 M (-0.77%)